BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 62810)

  • 41. Natural regulatory cells in murine bone marrow: inhibition of in vitro proliferative and cytotoxic responses to alloantigens.
    Dorshkind K; Klimpel GR; Rosse C
    J Immunol; 1980 Jun; 124(6):2584-8. PubMed ID: 6445382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
    Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mixed lymphocyte reactions: augmentation by drugs that inhibit stimulator cell protein synthesis.
    Metzler CM; Kostyk TG; Gershon RK
    J Immunol; 1976 Oct; 117(4):1295-9. PubMed ID: 135808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age-associated decline in the in vitro development of cytotoxic lymphocytes in NZB mice.
    Hirano T; Nordin AA
    J Immunol; 1976 Oct; 117(4):1093-8. PubMed ID: 135807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transient suppression of the humoral immune response mediated by a factor derived from specifically activated, doubly primed lymphoid cells.
    Kempf KE; Rubin AS
    J Immunol; 1977 Aug; 119(2):517-23. PubMed ID: 886185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of human NK cell cytotoxicity by an MLC-Generated cell population.
    D'Amore PJ; Golub SH
    J Immunol; 1985 Jan; 134(1):272-9. PubMed ID: 3155463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
    Brondz BD; Kahn ES; Chervonsky AV; Isakova VR; Apasov SG; Blandova ZK
    Exp Clin Immunogenet; 1987; 4(4):211-21. PubMed ID: 2978841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Nov; 117(5 Pt.2):1824-31. PubMed ID: 136471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
    Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A.
    Wang BS; Heacock EH; Chang-Xue Z; Tilney NL; Strom TB; Mannick JA
    J Immunol; 1982 Mar; 128(3):1382-5. PubMed ID: 6173434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
    Dziarski R
    J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens.
    Carnaud C; Fadaï-Ghotbi M; Lesavre P; Bach JF
    Eur J Immunol; 1977 Feb; 7(2):81-5. PubMed ID: 68884
    [No Abstract]   [Full Text] [Related]  

  • 58. Neonatally induced transplantation tolerance: in vitro evidence supporting a clonal inactivation mechanism.
    Brooks CG
    Eur J Immunol; 1975 Nov; 5(11):741-7. PubMed ID: 150333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clones of cytotoxic lymphocytes in culture: the difference in specificity between stimulated and nonstimulated cytotoxic lymphocytes.
    Ching LM; Walker KZ; Marbrook J
    Eur J Immunol; 1977 Dec; 7(12):846-50. PubMed ID: 147175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of specific suppressor T cells in vitro.
    Eardley DD; Gershon RK
    J Immunol; 1976 Jul; 117(1):313-8. PubMed ID: 58934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.